| |
Centre for Policy on Ageing | |
 | |
|
Clinical medication review by a pharmacist of elderly people living in care homes
— randomised controlled trial | | Author(s) | Arnold Geoffrey Zermansky, David Phillip Alldred, Duncan Robert Petty |
| Journal title | Age and Ageing, vol 35, no 6, November 2006 |
| Pages | pp 586-591 |
| Source | http://www.ageing.oxfordjournals.org |
| Keywords | Drugs ; Consultation ; General practice ; Clinical surveys ; Kirklees. |
| Annotation | Care home patients' medicines are reviewed infrequently by general practitioners (GPs). The authors report a pharmacist's clinical medication review in 65 care homes in Leeds of 661 residents aged 65+ on one or more medicines. The pharmacist reviewed 315 out of 331 (95.2%) patients in 6 months. A total of 62 out of 330 (18.8%) control patients were reviewed by their GP. The mean number of drug changes per patient were 3.1 for intervention and 2.4 for control group. There were respectively 0.8 and 1.3 falls per patient. There was no significant difference for GP consultations per patient, admission to hospital, deaths (51/331 and 48/330), Barthel score, Standardised Mini-Mental State Examination (SMMSE) score, and number and cost of drugs per patient. A total of 65.6% (565/747) pharmacist recommendations were accepted by the GP, and 76.6% (453/565) of accepted recommendations were implemented. GPs do not review most care home patients' medication. A clinical pharmacist can review them and make recommendations that are usually accepted. This leads to substantial changes in patients' medication regimens without change in drug costs. There is a reduction in the number of falls. (RH). |
| Accession Number | CPA-061211223 A |
| Classmark | LLD: LK6: L5: 3G: 88D |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|